Evaluation on Immunogenicity and Safety of Avian Influenza Isolate(ADL0401) as a Candidate for the Killed Vaccine against Low-Pathogenic Avian Influenza
2005
Lee, J.S. (Chungbuk National University, Cheongju, Republic of Korea) | Ha, D.H. (Chungbuk National University, Cheongju, Republic of Korea) | Kim, J.E. (Chungbuk National University, Cheongju, Republic of Korea) | Ha, B.D. (Chungbuk National University, Cheongju, Republic of Korea) | Mo, I.P. (Chungbuk National University, Cheongju, Republic of Korea), E-mail: [email protected]
Avian influenza (AI) virus (AIV) is distributed worldwide and it has been isolated from various species of wild and domestic birds. AI transfers with high speed and shows diverse pathogenicity syndroms. In Korea, several low pathogenic AIV, H9N2, have been isolated from the commercial farms with severe decrease of egg production and mortality resulted in severe economic loss since 1996. Therefore, it has been requested to develop AI vaccines to prevent clinical signs and economic losses from the field infection of AIV.
显示更多 [+] 显示较少 [-]